These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 22182853)
21. The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases. Chen J; Li C; Chen L Biomed Res Int; 2015; 2015():985814. PubMed ID: 26064975 [TBL] [Abstract][Full Text] [Related]
22. Advances in cell-based therapy for structural heart disease. Mazhari R; Hare JM Prog Cardiovasc Dis; 2007; 49(6):387-95. PubMed ID: 17498519 [TBL] [Abstract][Full Text] [Related]
23. From pluripotency to distinct cardiomyocyte subtypes. David R; Franz WM Physiology (Bethesda); 2012 Jun; 27(3):119-29. PubMed ID: 22689787 [TBL] [Abstract][Full Text] [Related]
24. Application of stem cell/growth factor system, as a multimodal therapy approach in regenerative medicine to improve cell therapy yields. Pourrajab F; Babaei Zarch M; Baghi Yazdi M; Rahimi Zarchi A; Vakili Zarch A Int J Cardiol; 2014 Apr; 173(1):12-9. PubMed ID: 24612559 [TBL] [Abstract][Full Text] [Related]
25. Pluripotent stem cells - a review of the current status in neural regeneration. Paspala SA; Murthy TV; Mahaboob VS; Habeeb MA Neurol India; 2011; 59(4):558-65. PubMed ID: 21891934 [TBL] [Abstract][Full Text] [Related]
26. Stem cells: potential therapy for age-related diseases. Kassem M Ann N Y Acad Sci; 2006 May; 1067():436-42. PubMed ID: 16804023 [TBL] [Abstract][Full Text] [Related]
28. Stem cells: the building blocks to repair the injured heart. Van Oorschot AA; Smits AM; Goumans MJ Panminerva Med; 2010 Jun; 52(2):97-110. PubMed ID: 20517194 [TBL] [Abstract][Full Text] [Related]
29. Challenges in deriving and utilizing stem cell-derived endothelial cells for regenerative medicine: a key issue in clinical therapeutic applications. Jalil RA; Neng LC; Kofidis T J Stem Cells; 2011; 6(2):93-9. PubMed ID: 22997849 [TBL] [Abstract][Full Text] [Related]
30. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Lian Q; Zhang Y; Zhang J; Zhang HK; Wu X; Zhang Y; Lam FF; Kang S; Xia JC; Lai WH; Au KW; Chow YY; Siu CW; Lee CN; Tse HF Circulation; 2010 Mar; 121(9):1113-23. PubMed ID: 20176987 [TBL] [Abstract][Full Text] [Related]
31. Current applications of human pluripotent stem cells: possibilities and challenges. Ho PJ; Yen ML; Yet SF; Yen BL Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556 [TBL] [Abstract][Full Text] [Related]
32. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials. Mizuno H Curr Opin Mol Ther; 2010 Aug; 12(4):442-9. PubMed ID: 20677095 [TBL] [Abstract][Full Text] [Related]
33. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells. Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827 [TBL] [Abstract][Full Text] [Related]
38. Differentiation of pluripotent stem cells for regenerative medicine. Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367 [TBL] [Abstract][Full Text] [Related]
39. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury? Salewski RP; Eftekharpour E; Fehlings MG J Cell Physiol; 2010 Mar; 222(3):515-21. PubMed ID: 20020443 [TBL] [Abstract][Full Text] [Related]